explore -WSS

explore

author：focus 2025-09-02 08:15:43 - browse：18

the Federal Trade Commission building and its brown sign — Adobe

A federal judge ordered Wednesday that Novant Health can move forward with its plan to buy two North Carolina hospitals, denying the Federal Trade Commission’s request for an injunction.

The FTC sued to block the deal in January, arguing that it would give Novant control of more than 65% of the region’s inpatient market. The case, one seeking to block nearby hospitals from merging and creating an even more powerful dominant player, is the FTC’s bread and butter. The agency has shied away from challenging cross-market and vertical mergers, but this one is right in its wheelhouse, which makes the setback surprising.

Under the deal, announced early last year, Novant would buy two hospitals in the same county from for-profit Community Health Systems for $320 million. The hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only a 25-minute drive from one another. Davis Regional used to be a full-service hospital, but is now a psychiatric hospital. The deal also includes a group of 24 doctors, a majority interest in an endoscopy center, and a holding in a planned surgery center.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Australia's humpback populations rebound raising hopes of marine scientists

WSS

Pfizer's Covid pill remains 89% effective in final analysis, company says

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

UnitedHealth sued over use of algorithm in Medicare Advantage plans

New case study details death in closely watched Alzhiemer's trial

White House drug czar issues call for 'recovery

Did the public have the right to know Arthur Ashe had AIDS?

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

knowledge

How one medical school became remarkably diverse

RaDonda Vaught case: a double standard for nurses, physicians

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

What is STAT's opinion section for?

What does generative AI mean for health care? We asked experts

Australia's humpback populations rebound raising hopes of marine scientists

What does generative AI mean for health care? We asked experts

White House drug czar issues call for 'recovery

Supreme Court strikes down use of affirmative action

Weight loss drugs should be covered by insurers, AMA says

hotspot

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Australia's humpback populations rebound raising hopes of marine scientists

Option Care buys Amedisys in $3.6 billion home care deal

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Carbon Health diabetes program, a test of data

A letter from the executive editor: STAT UnitedHealth investigation

Wikipedia

focus

focus

hotspot